Chromosomal fragile site FRA16D and DNA instability in cancer

Cancer Research

Volumn 60, Issue 6, 2000, Pages 1683-1689

  Mangelsdorf, Marie ^a   Ried, Karin ^a   Woollatt, Erica ^a   Dayan, Sonia ^a   Eyre, Helen ^a   Finnis, Merran ^a   Hobson, Lynne ^a   Nancarrow, Julie ^a   Venter, Deon ^b   Baker, Elizabeth ^a   Richards, Robert I ^a  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CONTIG; DNA;

ARTICLE; CANCER; CHROMOSOME FRAGILE SITE; CHROMOSOME TRANSLOCATION; GENE DELETION; GENETIC STABILITY; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; CHROMOSOME FRAGILE SITES; CHROMOSOME FRAGILITY; CHROMOSOME MAPPING; CHROMOSOMES, ARTIFICIAL, YEAST; CHROMOSOMES, HUMAN, PAIR 16; CLONING, MOLECULAR; DNA, NEOPLASM; HETEROZYGOTE; HOMOZYGOTE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MICROSATELLITE REPEATS; NEOPLASMS; SEQUENCE DELETION; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0034654641     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Yunis, J. J., and Soreng, A. L. Constitutive fragile sites and cancer. Science (Washington DC), 226: 1199-1204, 1984.
2. Hecht, F., and Sutherland, G. R. Fragile sites and cancer breakpoints. Cancer Genet. Cytogenet., 12: 179-181, 1984.
3. Simmers, R. N., Sutherland, G. R., West, A., Richards, R. I. Fragile sites at 16q22 are not at the breakpoint of the chromosomal rearrangement in AMMoL. Science (Washington DC), 236: 92-94, 1987.
4. Simmers, R. N., and Sutherland, G. R. Further localisation of ETS1 indicates that the chromosomal rearrangement in Ewing sarcoma does not occur at fra(11)(q23). Hum. Genet., 78: 144-147, 1998.
5. Sutherland, G. R. Fragile sites and cancer breakpoints: the pessimistic view. Cancer Genet. Cytogenet., 31: 5-7, 1988.
6. Sutherland, G. R., and Simmers, R. N. No statistical association between common fragile sites and nonrandom chromosome breakpoints in cancer cells. Hum. Genet., 78: 144-147, 1988.
7. Ohta, M., Inoue, H., Cotticelli, M. G., Kastury, K., Baffa, R. Palazzo, J., Siprashvilli, Z., Mori, M., McCue, P., Druck, T., Croce, C. M., and Huebner, K. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3:8) breakpoint, is abnormal in digestive tract cancers. Cell, 84: 587-597, 1996.
8. Friend, S. H., Bernards, R., Rogelj, S., Weinberg, R. A., Rapaport, J. M., Albert, D. M., and Dryja, T. P. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature (Lond.), 323: 643-646, 1986.
9. Fearon, E. R., Cho, K. R., Nigro, J. M., Kern, S. E., Simons, J. W., Ruppert, J. M., Hamilton, S. R., Preisinger, A. C., Thomas, G., Kinzler, K. W., and Vogelstein, B. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science (Washington DC), 247: 49-56, 1990.
10. Sozzi, G., Veronese, M. L., Negrini, M., Baffa, R., Cotticelli, M. G., Inoue, H., Tornielli, S., Pilotti, S., De Gregorio, L., Pastorino, U., Pierotti, M. A., Ohta, M., Huebner, K., and Croce, C. M. The FHIT gene at 3p14.2 is abnormal in lung cancer. Cell, 85: 17-26, 1996.
11. Siprashvilli, Z., Sozzi, G., Barnes, L. D., McCue, P., Robinson, A. K., Eryomin, V., Sard, L., Tagliabue, E., Greco, A., Fusetti, L., Schwartz, G., Pierotti, M., Croce, C., and Huebner, K. Replacement of Fhit in cancer cells suppresses tumourigenicity. Proc. Natl. Acad. Sci. USA, 94: 13771-13776, 1997.
12. Inoue, H., Ishii, H., Alder, H., Snyder, E., Druck, T., Huebner, K., and Croce, C. M. Sequence of the FRA3B common fragile site: implications for the mechanism of FHIT deletion. Proc. Natl. Acad. Sci. USA, 94: 14584-14589, 1997.
13. Huebner, K., Garrison, P. N., Barnes, L. D., and Croce, C. M. The role of the FHIT/FRA3B locus in cancer. Annu. Rev. Genet., 32: 7-31, 1998.
14. Le Beau, M. M., Drabkin, H., Glover, T. W., Gemmill, R., Rassool, F. V., McKeithen, T. W., and Smith, D. I. An FHIT tumour suppressor gene? Genes Chromosomes Cancer, 21: 281-289, 1998.
15. Sutherland, G. R., Baker, E., and Richards, R. I. Fragile sites still breaking. Trends Genet., 14: 501-506, 1998.
16. Otterson, G. A., Xiao, G. H., Geradts, J., Jin, F., Chen, W. D. Niklinska, W., Kaye, F. J., Yeung, R. S. Protein expression and functional analysis of the FHIT gene in human tumor cells. J. Natl. Cancer Inst., 18: 426-432, 1998.
17. Huang, H., Qian, C., Jenkins, R. B., and Smith, D. I. Fish mapping of YAC clones at human chromosomal band 7q31.2: identification of YACs spanning FRA7G within the common region of LOH in breast and prostate cancer. Genes Chromosomes Cancer, 21: 152-159, 1998.
18. Huang, H. H., Qian, J., Proffit, J., Wilber, K., Jenkins, R., and Smith, D. I. FRA7G extends over a broad region: coincidence of human endogenous retroviral sequences (HERV-H) and small polydipersed circular DNAs (spcDNA) and fragile sites. Oncogene, 16: 2311-2319, 1998.
19. Engelman, J. A., Zhang, X. L., and Lisanti, M. P. Genes encoding human caveolin-1 and -2 are co-localized to the D7S522 locus (7q31.1), a known fragile site (FRA7G) that is frequently deleted in human cancers. FEBS Lett. 438: 403-410, 1998.
20. Galbiati, F., Volonte, D., Engelman, J. A., Watanabe, G., Burk, R., Pestell, R. G., and Lisanti, M. P. Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade. EMBO J., 17: 6633-6648, 1998.
21. Coquelle, A., Pipiras, E., Toledo, F., Bultin, G., and DeBatisse, M. Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons. Cell, 89: 215-225, 1997.
22. Papiris, E., Coquelle, A., Bieth, A., and Debatisse, M. Interstitial deletions and intrachromosomal amplification initiated from a double-strand break targeted to a mammalian chromosome. EMBO J., 17: 325-333, 1998.
23. Chen, T., Sahin, A., and Aldaz, C. M. Deletion mapping of chromosome 16q in ductal carcinoma of the breast: refining a putative tumor suppressor gene region. Cancer Res., 56: 5605-5609, 1996.
24. Latil, A., Cussenot, O., Fournier, G., Driouch, K., and Lidereau, R. Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions. Cancer Res., 57: 1058-1062, 1997.
25. Yu, S., Mangelsdorf, M., Hewett, D., Hobson, L., Baker, E., Eyre, H., Lapsys, N., Le Paslier, D., Doggett, N., Sutherland, G. R., and Richards, R. I. Human chromosomal fragile site FRA16B is an amplified AT-rich minisatellite repeat. Cell, 88: 367-374, 1997.
26. Maw, M. A., Grundy, P. E., Millow, L. J. Eccles, M. R., Dunn, R. S., Smith, P. J., Feinberg, A. P., Law, D. J., Paterson, M. C., Telzerow, P. E., Callen, D. F., Thompson, A. D., Richards, R. I., Reeve, A. E. A third Wilms' tumour locus on chromosome 16q. Cancer Res., 52: 3094-3098, 1992.
27. Horwitz, M., Benson, K. F., Li, F-Q., Wolff, J., Leppert, M. F., Hobson, L., Mangelsdorf, M., Yu, S., Hewett, D., Richards, R. I., and Raskind, W. H. Genetic heterogeneity in familial acute myelogenous leukemia: evidence for a second locus at chromosome 16q21-23.2. Am. J. Hum. Genet., 61: 871-881, 1997.
28. Paige, A. J. W., Taylor, K. J., Stewart, A., Sgouros, J., Gabra, H., Sellar, G. C., Smyth, J. F., Porteous, D. J., Watson, J. E. V. A 700-kb physical map of a region of 16q23.2 homozygously deleted in multiple cancers and spanning the common fragile site FRA16D. Cancer Res. 60: 1690-1697, 2000.
29. Callen, D. F., Doggett, N. A., Stallings, R. L., Chen, L. Z., Whitmore, S. A., Lane, S. A., Nancarrow, J. K., Apostolou, S., Thompson, A. D., Lapsys, N. M., Eyre, H. J., Baker, E. G., Shen, Y., Holman, K., Phillips, H., Richards, R. I., Sutherland, G. R. High-resolution cytogenetic-based physical map of human chromosome 16. Genomics, 13: 1178-1185, 1992.
30. Gecz, J., Bielby, S., Sutherland, G. R., and Mulley, J. C. Gene structure and subcellular localisation of FMR2, a member of a new family of putative transcription activators. Genomics, 44: 201-213, 1997.
31. Sutherland, G. R., Baker, E., and Richards. R. I. Fragile sites. In: R. A. Meyer (ed.), Encyclopedia of Molecular Biology and Molecular Medicine, VCH, pp. 313-318. New York, 1996.
32. Callen, D. F., Baker, E., Eyre, H. J., Chernos, J. E., Bell, J. A., and Sutherland, G. R. Reassessment of two apparent deletions of chromosome 16p to an ins(11:16) and a t(1:6) by chromosome painting. Ann. Genet., 33: 219-221, 1990.
33. Chamberlain, J. S., Gibbs, R. A., Ranier, J. E., Nguyen, P. N., and Caskey, C. T. Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucleic Acids Res., 16: 1114-11156, 1988.
34. Beggs, A. H., Koenig, M., Boyce, F. M. and Kunkel, L. M. Detection of 98% of DMD/BMD gene deletions by polmerase chain reaction. Human Genet., 86: 45-48, 1990.
35. Richards, R. I., Holman, K., Lane, S., Sutherland, G. R., and Callen, D. F. Human chromosome 16 physical map: mapping of somatic cell hybrids using multiplex PCR deletion analysis of sequence lagged sites. Genomics, 10: 1047-1052, 1991.
36. Kremer, E., Pritchard, M., Lynch, M., Yu, S., Holman, K., Warren, S. T., Schlessinger, D., Sutherland, G. R., Richards, R. I. DNA instability at the fragile X maps to a trinucleotide repeat sequence p(CCG)n Science. 252, 1711-1714: 1991.
37. Hewett D. R., Handt, O., Hobson, L., Mangelsdorf, M., Eyre, H. J., Baker, E., Sutherland, G. R., Schuffenhauer, S., Mao, J., and Richards, R. I. FRA10B structure reveals common elements in repeat expansion and chromosomal fragile site genesis. Mol. Cell, 1: 773-781, 1998.
38. Palin, A. H., Critcher, R., Fitzgerald, D. J., Anderson, J. N., Farr, C. J. Direct cloning and analysis of DNA sequences from a region of the Chinese hamster genome associated with aphidicolin-sensitive fragility. J. Cell Sci., 111: 1623-1634, 1998.
39. Wilke, C. M., Hall, B. K., Hoge, A., Paradee, W., Smith, D. I., and Glover, T. W. FRA3B extends over a broad region and contains a spontaneous HPV16 integration site: direct evidence for the coincidence of viral integration sites and fragile sites. Hum. Mol. Genet., 5: 187-195, 1996.
40. Boldog, F., Gemmill, R. M., West, J., Robinson, M., Robinson, L., Li, E., Roche, J., Todd, S., Waggoner, B., Lundstrom, R., Jacobson, J., Mullokandov, M. R., Klinger, H., and Drabkin, H. A. Chromosome 3p14 homozygous deletions and sequence analysis of FRA3B. Hum. Mol. Genet. 6: 193-203, 1997.
41. Zimonjic, D. B., Druck, T., Ohta, M., Kastury, K., Croce, C. M., Popescu, N. C., and Huebner, K. Positions of chromosome 3p14.2 fragile sites (FRA3B) within the FHIT gene. Cancer Res, 57: 1166-1170, 1997.
42. Mishmar, D., Rahat, A., Scherer, S. W., Nyakatura, G., Hinzmann, B., Kohwi, Y., Mandel-Gutfroind, Y., Lee, J. R., Drescher, B., Sas, D. E., Marglat, H., Platzer, M., Weiss, A., Tsui, L-C., Rosenthal, A., and Kerem, B. Molecular characterization of a common fragile site (FRA7H) on human chromosome 7 by the cloning of a simian virus 40 integration site. Proc. Natl. Acad. Sci. USA, 14: 8141-8146, 1998.
43. Chesi, M., Bergsagel, P. L., Shonukan, O. O., Martelli, M. L., Brents, L. A., Chen, T., Schrok, E., Ried, T., and Kuehl, W. M. Frequent dysregulation of the c-MAF proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma. Blood, 91: 4457-4463, 1998.
44. Pekarsky, Y. Druck, T., Cotticelli, M. G., Ohta, M., Shou, J., Mendrola, J., Montgomery, J. C. Buchberg, A. M., Siracusa, L. D., Manenti, G., Fong, L. Y. Y., Dragani, T. A., Croce, C. M., and Huebner, K. The murine Fhit locus: isolation, characterization and expression in normal and tumor cells. Cancer Res., 58: 3401-3408, 1998.
45. Glover, T. W., Hoge, A., Miller, D. E., Ascara-Wilke, J. E., Adam, A. N., Dagenais, S. L., Wilke, C. M., Dierick, H. A., and Beer, D. G. The murine Fhit gene is highly similar to its human orthologue and maps to a common fragile site region. Cancer Res., 58: 3409-3414, 1998.
46. Ji, L., Fang, B., Yen, N., Fong, K., Minna, J. D., and Roth, J. A. Induction of apoptosis and inhibition of tumourigenecity and tumour growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression. Cancer Res., 59: 3333-3339, 1999.
47. Sard, L., Accornero, P., Tornielli, S., Delia, D., Bunone, G., Campiglio, M., Colombo, M. P., Gramegna, M., Croce, C. M., Pierotti, M. A., and Sozzi, G. The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control. Proc. Natl. Acad. Sci. USA, 96: 8489-8492, 1999.
48. LeBeau, M. M., Rassool, F. V., Neilly, M. E., Espinosa, R., Glover, T. W., Smith, D. I., and McKeithan, T. W. Replication of a common fragile site. FRA3B, occurs late is S phase and is delayed further upon induction: implications for the mechanism of fragile site induction. Hum. Mol. Genet., 7: 755-761, 1998.
49. Hansen, R. S., Canfield, T. K., Field, A. D., Mumm, S., Laird, C. D., and Gartler, S. M. A variable domain of delayed replication in FRAXA fragile X chromosomes: X inactivation-like spread of late replication. Proc. Natl. Acad. Sci. USA, 94: 4587-4592, 1997.
50. Subramanian, P. S., Nelson, D. L., and Chinault, A. C. Large Domains of apparent delayed replication timing associated with triplet repeat expansion at FRAXA and, FRAXE. Am. J. Hum. Genet., 59: 407-416, 1996.
51. Jones, C., Penny, L., Mattina, T., Yu, S., Baker, E., Voullaire, L., Langdon, W. Y., Sutherland, G. R., Richards, R. I., and Tunnacliffe, A. Association of a chromosome deletion syndrome with a fragile site wilhin the proto-oncogene CBL2. Nature (Lond.), 376: 145-149, 1995.